Cellular Organelles, Bioenergetics, and Photosynthetic Mechanisms

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/44

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering lysosomes, proteasomal degradation, mitochondrial dynamics and bioenergetics, and chloroplast-mediated photosynthesis from the lecture notes.

45 Terms

1
New cards

Christian de Duve

The scientist credited as the founder and discoverer of the lysosome.

2
New cards

Acid Phosphatase

The specific hydrolytic marker enzyme used to identify and distinguish lysosomes from other organelles.

3
New cards

Lysosomal Optimum pH

An acidic internal environment of approximately pH=5.0pH = 5.0, which maintains the activity of 4040 to 6060 hydrolytic enzymes and protects the cell from accidental self-digestion if enzymes leak into the cytoplasm at pH∼7.2pH \thicksim 7.2.

4
New cards

Heterophagy

The process by which a lysosome digests extracellular materials that have been engulfed or brought inside the cell.

5
New cards

Elie Metchnikoff

Scientist who coined the term phagocytosis (meaning eat, cavity) and won the Nobel Prize for his contributions involving probiotics, gerontology, and the cellular basis of immunity.

6
New cards

Myasthenia Gravis

A neuromuscular disorder causing droopy eyelids and muscle weakness, characterized by an autoimmune response where antibodies attack acetylcholine receptors at the neuromuscular junction.

7
New cards

Eserine

A pharmacological agent used to treat Myasthenia Gravis by blocking acetylcholinesterase, thereby preventing the breakdown of acetylcholine.

8
New cards

Vyvgart

A therapeutic antibody drug composed of the FcFc fragment of an IgGIgG antibody used to manage Myasthenia Gravis.

9
New cards

Dan Drachman's Experiments

Studies demonstrating the autoimmune origin of Myasthenia Gravis using ^3H\text{-\alpha-bungarotoxin} to bind to acetylcholine receptors (AChRAChR) and injecting Torpedo electroplax electric fish AChRAChR into mice to induce disease symptoms.

10
New cards

Autophagy

The cellular degradation and recycling pathway targeting a cell's own damaged components and organelles, which begins at the endoplasmic reticulum and uses LC3LC3 as a marker.

11
New cards

Bafilomycin A

An inhibitor that poisons the lysosomal H+H^+ pump, raising the internal lysosomal pHpH from 5.05.0 to 7.07.0.

12
New cards

Silicosis

A non-genetic, occupational miner's disease caused by the inhalation of silica particles that disrupt lysosomes and reduce pulmonary oxygen and carbon dioxide exchange.

13
New cards

Genzyme Sanofi

A Massachusetts biotechnology company that pioneered Enzyme Replacement Therapy (ERTERT) for the treatment of lysosomal storage diseases.

14
New cards

Tay-Sachs Disease

A hereditary lysosomal storage disorder caused by a lack or defect in Hexosaminidase A, leading to the toxic accumulation of ganglioside GM2GM2 primarily in the brain.

15
New cards

Hurler Syndrome

Mucopolysaccharidosis type I (also known as gargoylism) caused by a deficiency in α-L-iduronidase\alpha\text{-L-iduronidase}, resulting in glycosaminoglycan accumulation and treated with the enzyme replacement therapy Aldurazyme.

16
New cards

I-Cell Disease

A rare hereditary disorder (1 in 700,0001\text{ in }700,000 births) resulting from a failure to attach mannose-6-phosphate (M6PM6P) targeting signals to acid hydrolases, causing the enzymes to be misrouted and secreted extracellularly.

17
New cards

Gaucher's Disease

The most common lysosomal storage disease, characterized by a glucocerebrosidase deficiency, accumulation of glucocerebroside, hepatosplenomegaly, and erosion of long bones; treated with Ceredase or Cerezyme.

18
New cards

Pompe Disease

A lysosomal storage disease caused by an acid α-glucosidase\alpha\text{-glucosidase} deficiency resulting in glycogen accumulation, managed clinically using the ERTERT drug Myozyme.

19
New cards

Proteasome

A massive, protein-degrading macromolecular complex (∼30,000\thicksim 30,000 per typical cell) responsible for clearing misfolded proteins tagged by the unfolded protein response (UPRUPR) and regulating apoptosis and the cell cycle.

20
New cards

Ubiquitination

The post-translational covalent modification of misfolded or target proteins with ubiquitin, serving as the required signal for recognition and degradation by the proteasome.

21
New cards

Bortezomib

A clinical proteasome inhibitor used to treat relapsed multiple myeloma by exacerbating endoplasmic reticulum stress and driving overloaded cancer cells into apoptosis.

22
New cards

Porin (VDAC)

A voltage-dependent anion channel protein situated in the outer mitochondrial membrane that forms large aqueous channels permitting the passage of molecules up to 5,000 Da5,000\text{ Da}.

23
New cards

PIGBOS

A protein located on the outer mitochondrial membrane that communicates directly with the rough endoplasmic reticulum to regulate the unfolded protein response (UPRUPR).

24
New cards

Cardiolipin

A four-fatty-acid lipid found in the inner mitochondrial membrane that enhances membrane impermeability to ions, increases electrical resistance to bolster the proton motive force, and anchors the electron transport complexes together.

25
New cards

ER MAM (Mitochondrial-Associated Membrane)

A specialized subdomain of the endoplasmic reticulum that wraps around mitochondria to regulate calcium homeostasis, lipid metabolism, mitochondrial fission constrictions, autophagy, and mitophagy.

26
New cards

Tunneling Nanotubes

Intercellular conduits containing F-actinF\text{-actin} filaments that facilitate cell-to-cell transfer of mitochondria and other structures for metabolic rescue, tissue repair, and regenerative support.

27
New cards

MPTP (Mitochondrial Permeability Transition Pore)

A channel complex regulated by anti-apoptotic Bcl-2Bcl\text{-}2/Bcl-xLBcl\text{-xL} (closed state) and pro-apoptotic BaxBax/BakBak oligomers (open state); opening allows Cytochrome c release into the cytoplasm under intrinsic cellular stress.

28
New cards

Cytochrome c

The only soluble electron carrier of the mitochondrial electron transport chain; upon release through the open MPTPMPTP, it binds to APAF-1APAF\text{-}1 to trigger procaspase activation and drive apoptosis.

29
New cards

Cyclosporin A

An immunosuppressive compound that blocks the opening of the MPTPMPTP, mitigating intrinsic-stress-induced apoptosis to preserve stem cell viability during transport and storage.

30
New cards

Warburg Effect

The metabolic shift characteristic of many cancer cells, marked by the overexpression of Glut1Glut1, Glut3Glut3, PFKPFK, and LDHLDH, relying predominantly on aerobic glycolysis rather than mitochondrial oxidative phosphorylation.

31
New cards

Galactose Medium Assay

A laboratory screening method that replaces glucose with galactose in cultured hepatoma cells (HepG2HepG2) to force reliance on mitochondrial ATPATP generation, exposing otherwise masked drug-induced mitochondrial toxicity.

32
New cards

Chemiosmotic Hypothesis

The concept pioneered by Peter Mitchell proposing that an electrochemical proton gradient (ΔVm∼−200 mV\Delta V_m \thicksim -200\text{ mV}) across the inner mitochondrial membrane serves as the energetic bridge driving ATPATP synthesis by F0F1 ATPF_0F_1\text{ ATP} synthase.

33
New cards

2,4-Dinitrophenol (DNP)

A lipid-soluble weak acid that acts as a proton ionophore, dissipating the inner mitochondrial proton gradient and uncoupling the electron transport chain from ATPATP synthase.

34
New cards

Thermogenin (UCP1)

A physiological mitochondrial uncoupling protein found in the brown fat of newborns that dissipates the proton gradient to generate heat through non-shivering thermogenesis.

35
New cards

Oligomycin

An antibiotic agent that directly inhibits the F0F1 ATPF_0F_1\text{ ATP} synthase by blocking proton translocation through the F0F_0 subunit.

36
New cards

Rhodamine 123

The first vital fluorescent dye specific for mitochondria, discovered by Lan Bo Chen, which accumulates in and stains functional mitochondria proportionally to their negative inner membrane potential.

37
New cards

Theodor Engelmann Experiment

An experiment using the ribbon-like chloroplasts of Spirogyra illuminated with dispersed light wavelengths to demonstrate that aerotactic bacteria migrate to sites of oxygen generation illuminated by red and purple light.

38
New cards

Hill and van Niel Experiments

Pioneering 1930s studies using purple sulfur bacteria demonstrating that photosynthesis is a light-dependent oxidation-reduction reaction where liberated oxygen originates from water.

39
New cards

NeoPX (Neoplants)

A genetically engineered indoor houseplant developed in Paris designed to capture and eliminate volatile organic compounds (VOCsVOCs) from air.

40
New cards

Phycoerythrin

An accessory light-harvesting pigment employed by deep ocean algae that captures green light wavelengths in ocean depths depleted of red and blue light.

41
New cards

Resonance Energy Transfer

The non-radiative transfer of excitation energy across pigment molecules within light-harvesting antenna complexes until it reaches the reaction-center chlorophyll a, transferring energy without passing electrons.

42
New cards

Photoinhibition

A light-induced reduction in photosynthetic efficiency that primarily damages Photosystem II (PSIIPSII), particularly upon exposure to excess blue light.

43
New cards

D1 Protein

A 32,000 Da32,000\text{ Da} core structural protein subunit of Photosystem II that displays a high physiological turnover rate and is selectively degraded and resynthesized during photoinhibition recovery.

44
New cards

Rubisco

The enzyme catalyzing the initial step of carbon fixation, composed of nuclear- and chloroplast-encoded subunits; possesses low carbon dioxide affinity and can catalyze wasteful photorespiration when oxygen levels exceed carbon dioxide.

45
New cards

PEP Carboxylase

The primary carbon-fixing enzyme utilized by C4C_4 plants that exhibits a high affinity for carbon dioxide, pumping concentrated CO2CO_2 into bundle sheath cells to optimize Rubisco efficiency.